Correct dosage and use of albuterol/budesonide inhalation spray (Airsupra)
Salbutamol/budesonide inhalation spray (Airsupra) is a compound drug mainly used to treat asthma patients, especially in response to acute symptoms, showing good efficacy. The drug combines albuterol, a short-acting β2-adrenergic agonist that can quickly relax airway smooth muscles, and budesonide, an inhaled corticosteroid designed to reduce the inflammatory response in the airways and help long-term control of asthma symptoms. Airsupra is designed to provide fast and effective wheezing relief when needed and to assist in daily management.

During the use of Airsupra, the usual dosage for adult patients is to take 2 inhalations by oral inhalation according to the needs of individual asthma symptoms. Each dose is 90 micrograms of albuterol and 80 micrograms of budesonide. It is important to note that patients should not exceed the usage limit of 6 doses, or a maximum of 12 inhalations, within a 24-hour period to avoid the risk of overdose and related side effects. Therefore, patients need to strictly follow the doctor's instructions when using it and arrange the medication time reasonably.
Before using Airsupra for the first timePatients should prime the inhaler to ensure normal drug release. If the inhaler is not used within 7 days, or is dropped during use or after cleaning, it must be refilled to ensure the effectiveness of the drug. At the same time, when the dose counter shows 0, the inhaler should be discarded immediately and cannot be used anymore. This is crucial to ensure patient safety and therapeutic effect.
AlthoughAirsupra is effective and safe in most cases, it can cause serious side effects, so patients need to remain vigilant during use. If you have difficulty breathing, worsening cough, or other uncomfortable symptoms, you should stop taking the medicine in time and consult a medical professional. In short, albuterol/budesonide inhalation spray provides a convenient and effective treatment plan for asthma patients. Through reasonable dosage and usage, patients can better control their condition and improve their quality of life.
Reference link:https://www.drugs.com/airsupra.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)